Authors: HERZIG MCS TREVINO AV ARNETT BM WOYNAROWSKI JM

Citation: Mcs. Herzig et al., SITE-SPECIFICITY AND REGION-SPECIFICITY OF TALLIMUSTINE LESIONS IN CELLULAR DNA, Annals of oncology, 9, 1998, pp. 527-527

Authors: WOYNAROWSKI JM HARDIES SC TREVINO AV ARNETT BM

Citation: Jm. Woynarowski et al., TARGETING OF AT-RICH ISLANDS IN GENOMIC DNA BY BIZELESIN, AN AT-SPECIFIC DNA-REACTIVE ANTITUMOR DRUG, Annals of oncology, 9, 1998, pp. 528-528

Authors: ANDREWS JM OGLESBEE MJ TREVINO AV GUYOT DJ NEWBOUND GC LAIRMORE MD

Citation: Jm. Andrews et al., ENHANCED HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I EXPRESSION FOLLOWING INDUCTION OF THE CELLULAR STRESS-RESPONSE, Virology, 208(2), 1995, pp. 816-820

Authors: LAIRMORE MD DIGEORGE AM CONRAD SF TREVINO AV LAL RB KAUMAYA PTP

Citation: Md. Lairmore et al., HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 PEPTIDES IN CHIMERIC AND MULTIVALENT CONSTRUCTS WITH PROMISCUOUS T-CELL EPITOPES ENHANCE IMMUNOGENICITY AND OVERCOME GENETIC RESTRICTION, Journal of virology, 69(10), 1995, pp. 6077-6089

Authors: ERICSON JG TREVINO AV TOEDTER GP MATHES LE NEWBOUND GC LAIRMORE MD

Citation: Jg. Ericson et al., EFFECTS OF WHOLE-BLOOD LYSIS AND FIXATION ON THE INFECTIVITY OF HUMANT-LYMPHOTROPIC VIRUS TYPE-1 (HTLV-I), Cytometry, 18(1), 1994, pp. 49-54